The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Health Care Select Sector SPDR

NYSE: XLV
Last

(U.S.) $69.61

Today's change+0.31 +0.45%
Updated May 5 3:59 PM -4GMT. Delayed by at least 15 minutes.
 

Health Care Select Sector SPDR

NYSE: XLV
Last

(U.S.) $69.61

Today's change+0.31 +0.45%
Updated May 5 3:59 PM -4GMT. Delayed by at least 15 minutes.

Health Care Select Sector SPDR up (U.S.)$0.31

Health Care Select Sector SPDR closed up Thursday by (U.S.)$0.31 or 0.45% to (U.S.)$69.61. Over the last five days, shares have lost 1.82% and are down 3.36% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $69.31
  • Previous close(U.S.) $69.30
  • High(U.S.) $69.69
  • Low(U.S.) $69.16
  • Bid / Ask(U.S.) $69.61 / (U.S.) $69.62
  • YTD % change-3.36%
  • Volume9,173,963
  • Average volume (10-day)11,341,156
  • Average volume (1-month)11,332,393
  • Average volume (3-month)13,244,796
  • 52-week range(U.S.) $56.63 to (U.S.) $77.40
  • Beta0.82
  • Trailing P/E5.39×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.27
  • Dividend yield1.82%
  • Trailing EPS(U.S.) $12.92
Updated May 5 3:59 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1,414.10%

Based on its net profit margin of 1,414.10%, Health Care Select Sector SPDR is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:FinancialsIndustry:Investment Trusts

Latest Company News

View more News

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q2/2014Q4/2013Q2/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Mar 31, 201403/31/2014Sep 30, 201309/30/2013Mar 31, 201303/31/2013
Revenue83746863
Total other revenue--------
Total revenue83746863
Gross profit--------
Total cost of revenue--------
Total operating expense7735
Selling / general / administrative7735
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income76676558
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets8761,204663833
Other--------
Income before tax9521,271728891
Income after tax9521,271728891
Income tax, total0000
Net income9521,271728891
Total adjustments to net income--------
Net income before extra. items9521,271728891
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9521,271728891
Inc. avail. to common incl. extra. items9521,271728891
Diluted net income9521,271728891
Dilution adjustment--------
Diluted weighted average shares187163140155
Diluted EPS excluding extraordinary itemsvalue per share5.107.825.195.73
Dividends per sharevalue per share0.440.470.410.41
Diluted normalized EPSvalue per share0.410.410.460.38